Schedule 13G ownership disclosure
AMBRX BIOPHARMA INC
Security class unavailable · CUSIP: 02290A102
Event date: 2023-03-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.4400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-23-000830
- Form type
- SC 13G
- Filer
- Ambrx Biopharma Cayman, Inc.
- CIK
- CIK 1836056
- Filed
- Mar 13, 2023
- Reporting period
- Mar 03, 2023
- Description
- Schedule 13G beneficial ownership